Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
An announcement from Shanghai Bio-Heart Biological Technology Co., Ltd. Class H ( (HK:2185) ) is now available.
Shanghai Bio-heart Biological Technology Co., Ltd. has announced an unlisted foreign shareholders’ class meeting scheduled for February 13, 2025, to discuss and vote on proposed amendments to the company’s articles of association. This meeting reflects the company’s ongoing efforts to refine its corporate governance structure, potentially impacting its operations and stakeholder relationships.
More about Shanghai Bio-Heart Biological Technology Co., Ltd. Class H
Shanghai Bio-heart Biological Technology Co., Ltd. is a joint stock company based in the People’s Republic of China. Operating within the biotechnology sector, it focuses on developing and delivering biological technologies with a market emphasis in Shanghai’s East Zhangjiang Hi-Tech Park.
YTD Price Performance: -8.54%
Average Trading Volume: 26,992
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$627.8M
See more data about 2185 stock on TipRanks’ Stock Analysis page.
